- Home
- MRNA vs SF Comparison
MRNA vs SF Comparison
Compare MRNA & SF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- SF
- Stock Information
- Founded
- MRNA 2010
- SF 1890
- Country
- MRNA United States
- SF United States
- Employees
- MRNA 5800
- SF N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- SF Investment Bankers/Brokers/Service
- Sector
- MRNA Health Care
- SF Finance
- Exchange
- MRNA Nasdaq
- SF Nasdaq
- Market Cap
- MRNA 10.3B
- SF 9.8B
- IPO Year
- MRNA 2018
- SF N/A
- Fundamental
- Price
- MRNA $25.90
- SF $97.47
- Analyst Decision
- MRNA Hold
- SF Hold
- Analyst Count
- MRNA 19
- SF 8
- Target Price
- MRNA $48.13
- SF $105.14
- AVG Volume (30 Days)
- MRNA 10.5M
- SF 581.7K
- Earning Date
- MRNA 07-31-2025
- SF 07-23-2025
- Dividend Yield
- MRNA N/A
- SF 1.89%
- EPS Growth
- MRNA N/A
- SF 19.51
- EPS
- MRNA N/A
- SF 5.24
- Revenue
- MRNA $3,177,000,000.00
- SF $5,030,597,000.00
- Revenue This Year
- MRNA N/A
- SF $7.38
- Revenue Next Year
- MRNA $9.87
- SF $9.94
- P/E Ratio
- MRNA N/A
- SF $18.57
- Revenue Growth
- MRNA N/A
- SF 14.86
- 52 Week Low
- MRNA $23.15
- SF $73.27
- 52 Week High
- MRNA $138.07
- SF $120.64
- Technical
- Relative Strength Index (RSI)
- MRNA 46.10
- SF 57.72
- Support Level
- MRNA $25.06
- SF $95.60
- Resistance Level
- MRNA $28.72
- SF $98.33
- Average True Range (ATR)
- MRNA 1.18
- SF 2.00
- MACD
- MRNA -0.18
- SF 0.00
- Stochastic Oscillator
- MRNA 20.34
- SF 86.81
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About SF Stifel Financial Corporation
Stifel Financial is a middle-market-focused investment bank that produces more than 90% of its revenue in the United States. Approximately 67% of the company's net revenue is derived from its global wealth management division, which supports over 2,000 financial advisors, with the remainder coming from its institutional securities business. Stifel has a history of being an active acquirer of other financial-services firms.